About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Integrated Whole-Genome Analysis of Hematologic Disorders

NCT01108159·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Stanford University

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. 18 years of age or older
2. Patient meets the clinical and/or pathologic criteria for the hematologic disorder being examined.
3. Patient is willing to provide a skin biopsy and five 10 mL tubes of peripheral blood.

You may not be if

1. Less than 18 years of age
2. Patient is not willing to provide a skin biopsy and five 10 mL tubes of peripheral blood.

The record

StatusCompleted

PhaseNo phase

Taking part35

StartedSep 2009

UpdatedMay 31, 2018

Conditions

Hematologic Diseases

Where1

Stanford University School of Medicine
Stanford, California, United States

Clareo Health | Integrated Whole-Genome Analysis of Hematologic Disorders